TGX.NYSE 10X Genomics Trend Cloud Study Potential 100% Upside.

15 Mei

10X Genomics Trend Cloud Study shows a Potential 100% Upside.

This Ticker is way oversold and a Double Bottom is Seen.

Very Risky and Speculative. I'm Nibbling a few $100.

As always, please get a few outside Expert's Advice before making Trade or Investment Decisions.

Should you appreciate my Chart Studies, Smash That Rocket Boost Button. It's Just a Click away.

Regards Graham.

17 Jun

Nota

As normal will need a Catalyst OR RISK ON Sentiment. As Said I'm nibbling on this one. Should there be a FED rate Cut the down Momentum will Reverse IMO. I'm currently in a small loss scenario - however it's important to be patient and try not to destroy ones Capital. I'm Holding for Now and will watch till a potential Rate Cut.

2 Jul

Nota

Holding for now. Has performed worse than anticipated.
Conviction is Required.

18 Jul

Nota

On My Chart this on a Wave -9 Down.
Due for a reversal soon as very oversold.
However my strategy is WAIT.

25 Jul

Nota

Buy.
Canaccord Genuity Adjusts Price Target on 10x to $32 From $50, Maintains Buy Rating.

6 Ogo

Nota

The Japanese Carry Trade Has Distorted Many Stocks and Trades.
I did Dip Buy a Few $ in anticipation.

27 Ogo

Nota

10x Genomics Executives Sell Shares to Cover their Tax Obligations.
Paying Tax via Share Options is normal and expected.
Holding.

3 Sep

Nota

10x Genomics Price Target Announced at $35 a Share by Leerink Partners.

6 Sep

Nota

10x Genomics Price Target Maintained With a $30 a Share by Stephens & Co.
Volatile Markets.
Difficult to buy now. but Holding.

13 Sep

Nota

Remember to always set your Stop Loss at a reasonable value to maintain ones capital. Adobe is an example.

10 Okt

Nota

Gene Sequencing Tech Provider 10x Genomics' Q3 Sales Fall Short On Expectations, But CEO Sees Opportunity Ahead. Shares Tank.

10 Okt

Nota

Nasty One.
10x Genomics Price Target Cut to $20 a Share From $32 by Canaccord Genuity.
Canaccord Genuity now moved Down on my Ranking to 30% Reliable. Which is Useless IMO.

15 Nov

Dagangan aktif

Recent JFKJ to Health Minister by Trump and his Stance on Vaccines shows a sell.
I'm Out.

22 Nov

Dagangan ditutup: sasaran tercapai

I could start to nibble, based on activists convincing JFK about VACs.

22 Nov

Nota

Whilst this Ticker is not a VAC stock, there is sympathy trades.